News and Updates
- A unified gateway for discovery, access and sharing of datasets and biosamples
- New research collaboration aims to analyze 12 key dementia risk factors across the U.S. to uncover potential insights.
- Solanezumab Phase 3 Study Data from Lilly is Now Available on AD Workbench
Watch Our Video
For more information, please contact media@alzheimersdata.org.